Alunbrig Brigatinib 180mg Tablet 28’s
Manufacturer: TAKEDA PHARMACEUTICALS INDIA PVT LTD
Salt: BRIGATINIB 180MG
Category: Anti-Cancer
Price: $2265
Availability: In Stock
Alunbrig 180mg Tablet is an anticancer agent used to treat non-small cell lung cancer (NSCLC), containing the active ingredient Brigatinib. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) that block abnormal proteins responsible for cancer cell growth.
Alunbrig 180mg Tablet prescribed for patients with ALK-positive (anaplastic lymphoma kinase-positive) NSCLC who have shown disease progression or intolerance to previous ALK inhibitors. It helps prevent cancer cells from multiplying and spreading by targeting specific enzymes involved in tumor growth.
This drug is contraindicated in individuals with known hypersensitivity to Alunbrig 180mg Tablet or its components. Stop using it and consult your doctor immediately if you experience allergic reactions such as rash, swelling, or breathing difficulty.
If you are pregnant, planning pregnancy, or suspect pregnancy, consult your doctor before taking Alunbrig 180mg Tablet, as it may cause serious harm to the fetus. Similarly, consult your physician if you are breastfeeding or planning to breastfeed. Your doctor will assess your medical history and other medicines to ensure safe use. Alunbrig price varies by retailer and location.
- Treatment of ALK-positive non-small cell lung cancer (NSCLC).
- Managing disease progression in patients previously treated with other ALK inhibitors.
- Reducing tumor growth and preventing metastasis.
Alunbrig Brigatinib 180mg Tablet 28’s
Product Information
What is Alunbrig Brigatinib 180mg Tablet 28’s?
Alunbrig 180mg Tablet is an anticancer agent used to treat non-small cell lung cancer (NSCLC), containing the active ingredient Brigatinib. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) that block abnormal proteins responsible for cancer cell growth.
Alunbrig 180mg Tablet prescribed for patients with ALK-positive (anaplastic lymphoma kinase-positive) NSCLC who have shown disease progression or intolerance to previous ALK inhibitors. It helps prevent cancer cells from multiplying and spreading by targeting specific enzymes involved in tumor growth.
This drug is contraindicated in individuals with known hypersensitivity to Alunbrig 180mg Tablet or its components. Stop using it and consult your doctor immediately if you experience allergic reactions such as rash, swelling, or breathing difficulty.
If you are pregnant, planning pregnancy, or suspect pregnancy, consult your doctor before taking Alunbrig 180mg Tablet, as it may cause serious harm to the fetus. Similarly, consult your physician if you are breastfeeding or planning to breastfeed. Your doctor will assess your medical history and other medicines to ensure safe use. Alunbrig price varies by retailer and location.
Indications for Alunbrig Brigatinib 180mg Tablet 28’s
- Treatment of ALK-positive non-small cell lung cancer (NSCLC).
- Managing disease progression in patients previously treated with other ALK inhibitors.
- Reducing tumor growth and preventing metastasis.
Therapeutic Effects of Alunbrig Brigatinib 180mg Tablet 28’s
Brigatinib works by selectively inhibiting the activity of the ALK protein and other kinases involved in cancer cell proliferation. By blocking these enzymes, it helps prevent tumor cells from multiplying, spreading, and surviving, thereby slowing the progression of lung cancer.
How to consume Alunbrig Brigatinib 180mg Tablet 28’s
- Take exactly as prescribed by your oncologist.
- Usually taken once daily, with or without food.
- Swallow the tablet whole; do not crush, chew, or split.
- Follow the prescribed dosage schedule strictly.
- If a dose is missed, take it as soon as you remember unless it’s near the next dose. Do not double the dose.
Side Effects of Alunbrig Brigatinib 180mg Tablet 28’s
Common side effects:
- Nausea
- Fatigue
- Diarrhoea
- Increased blood pressure
- Cough
Serious side effects (seek medical help immediately):
- Lung problems (pneumonitis, interstitial lung disease)
- Liver enzyme abnormalities
- Severe allergic reactions (rash, swelling, difficulty breathing)
- High blood pressure
- Visual disturbances
Drug Interactions
Alunbrig 180mg Tablet may interact with:
Strong CYP3A inhibitors (e.g., ketoconazole) that can increase brigatinib levels in the blood.
CYP3A inducers (e.g., rifampin) that can reduce its effectiveness.
Other anticancer drugs increase the risk of side effects like heart rhythm problems or lung toxicity.
Always inform your doctor of all other medications, including over-the-counter drugs and herbal supplements.
Storage & Handling
- Store below 30°C in a dry place.
- Protect from direct sunlight and moisture.
- Keep out of reach of children.
Expert Advice
- Take Alunbrig 180mg Tablet at the same time every day for a consistent effect.
- Keep regular medical follow-ups for monitoring side effects and treatment progress.
- Report any unusual symptoms, especially breathing difficulties, to your doctor immediately.
- Do not stop treatment suddenly without medical advice.
Worldwide Shipping & Delivery
We provide specialized tracked delivery for Alunbrig Brigatinib 180mg Tablet 28’s to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.
- USA Shipping
- UK Delivery
- UAE & Middle East
- Germany & EU
- Australia
- Canada
Professional Safety Guidelines for Alunbrig Brigatinib 180mg Tablet 28’s

Pregnancy
UnsafeIt is recommended to avoid this medication during pregnancy as Alunbrig 180mg Tablet may cause foetal harm. Inform your doctor if you are pregnant, suspect pregnancy, or planning to become pregnant before starting treatment.

BreastFeeding
Consult your doctorIt is unknown whether Alunbrig 180mg Tablet passes into breast milk. Consult your doctor before using this medicine while breastfeeding.

Liver
Consult your doctorAlunbrig 180mg Tablet is metabolized by the liver and may cause elevated liver enzymes or liver dysfunction. Inform your doctor if you have liver disease before starting treatment.

Lungs
Consult your doctorAlunbrig 180mg Tablet may cause serious lung-related side effects such as interstitial lung disease or pneumonitis. Inform your doctor if you have a history of lung problems or experience shortness of breath before starting treatment.

Alcohol
Consult your doctorThere is limited data on the safety of alcohol use with Alunbrig 180mg Tablet. It may increase the risk of side effects such as drowsiness or liver issues. Please consult your physician.

Driving
Consult your doctorAlunbrig 180mg Tablet may cause dizziness or fatigue. Avoid driving or operating heavy machinery until you understand how the drug affects you.